The Aim of This Study is to Determine if Oocyte Sorting for Group Culture Using an Artificial Intelligence Image Analysis Tool (MagentaTM) Increases the Usable Blastocyst Yield and Subsequent Pregnancy in Patients Undergoing IVF
Ovation Fertility · with Future Fertility Inc. · NCT06521372
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 450
- US sites recruiting
- 3
- Study start
- January 1, 2024
- Record last updated
- July 26, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The aim of this study is to determine if oocyte sorting for group culture using an artificial intelligence image analysis tool (MagentaTM) increases the usable blastocyst yield and subsequent pregnancy in patients undergoing IVF.
Being studied: Magenta AI image analysis tool
Conditions: Infertility Primary
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Fresh MII oocytes
- ICSI cycles with patient's or donor's sperm
- Patient's or donor's oocytes
- Full IVF cycle information available (including total number of oocytes retrieved, total MII oocytes, fertilization, embryo and blastocyst development, as well as ploidy status or implantation results, and 6-7 week ultrasound, if applicable)
- Good quality images of MII oocytes taken with a specified camera (Basler) and Future Fertility Software
- Single embryo transfers (SETs) at blastocyst stage.
- Blastocyst freeze-all cycles
Exclusion Criteria
- Severe male factor infertility (\<1 million motile), including surgically retrieved sperm.
- ICSI cycles inseminating in vitro matured (IVM) oocytes
- Rescue ICSI oocytes (oocytes failed standard IVF and are re-inseminated by ICSI)
- Low quality images - Poor quality images on day of upload or before unblinding
- Lack of correlating reproductive outcomes (full IVF lab results not available).
- Autologous or donor frozen/warmed oocytes
- Day 3 embryo transfers or cleavage stage embryo freezing
- Patients with less than 6 mature oocytes
Recruiting US locations
Ovation Fertility Las Vegas
Las Vegas, NV 89113
Site contact: Matthew VerMilyea, PhD · 512-980-0310 · tex@ovationfertility.com
Ovation Fertility Cincinnati
Cincinnati, OH 45209
Site contact: Matthew VerMilyea, PhD · 512-980-0310 · tex@ovationfertility.com
Ovation Fertility - Nashville
Nashville, TN 37203
Site contact: Matthew VerMilyea, PhD · 512-980-0310 · tex@ovationfertility.com
Similar studies in Nevada
All women’s health studies in Nevada →- RecruitingHealthy volunteersPhase 1
A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgestrel TDS in Healthy Postmenopausal Subjects
Corium Innovations, Inc.
- Location
- Las Vegas, NV
- Eligibility basics
- Ages 40–75 · Women only
- RecruitingHealthy volunteers
A Clinical Trial to Evaluate the Effects of the Kaia Relief - Cycle System on Premenstrual Symptom Severity, Menstrual Discomfort, and Overall Well-Being in Premenopausal Women.
Vivance Group
- Location
- Las Vegas, NV
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingHealthy volunteersPhase 4
The Role of hCG in Thawed Embryo Transfer
Fertility Center of Las Vegas
- Location
- Las Vegas, NV
- Eligibility basics
- Ages 18+ · Women only
- RecruitingPhase 2
RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder
Vensica Therapeutics Ltd.
- Location
- Reno, NV + 2 other US sites
- Eligibility basics
- Ages 18–80 · Women only